Several other equities research analysts also recently weighed in on the stock. Goldman Sachs Group downgraded shares of Delek US from a “buy” rating to a “neutral” rating and decreased their price target for the company from $44.00 to $42.00 in a research note on Tuesday, April 16th. Raymond James decreased their price target on shares of Delek US from $46.00 to $45.00 and set a “strong-buy” rating for the company in a research note on Wednesday, April 10th. Barclays reaffirmed a “buy” rating and issued a $51.00 price target on shares of Delek US in a research note on Thursday, February 21st. Mizuho reaffirmed a “buy” rating and issued a $60.00 price target on shares of Delek US in a research note on Thursday, February 21st. Finally, Zacks Investment Research cut shares of Delek US from a “hold” rating to a “sell” rating in a report on Monday, January 21st. Two research analysts have rated the stock with a sell rating, eight have assigned a hold rating, four have given a buy rating and one has given a strong buy rating to the company. Delek US currently has a consensus rating of “Hold” and an average target price of $49.39.
NYSE DK traded up $0.94 during mid-day trading on Friday, reaching $36.00. 975,784 shares of the stock were exchanged, compared to its average volume of 1,119,641. Delek US has a one year low of $29.51 and a one year high of $61.57. The company has a market capitalization of $2.79 billion, a PE ratio of 7.50, a P/E/G ratio of 0.97 and a beta of 1.31. The company has a quick ratio of 1.04, a current ratio of 1.45 and a debt-to-equity ratio of 0.97.
In other news, CFO Assi Ginzburg sold 10,478 shares of Delek US stock in a transaction dated Friday, April 5th. The shares were sold at an average price of $38.95, for a total transaction of $408,118.10. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. 1.20% of the stock is owned by company insiders.
A number of institutional investors have recently added to or reduced their stakes in the stock. Advisors Asset Management Inc. lifted its position in shares of Delek US by 652.3% in the third quarter. Advisors Asset Management Inc. now owns 9,216 shares of the oil and gas company’s stock valued at $391,000 after acquiring an additional 7,991 shares in the last quarter. AQR Capital Management LLC lifted its position in shares of Delek US by 16.8% in the third quarter. AQR Capital Management LLC now owns 200,833 shares of the oil and gas company’s stock valued at $8,521,000 after acquiring an additional 28,912 shares in the last quarter. Vanguard Group Inc. lifted its position in shares of Delek US by 0.8% in the third quarter. Vanguard Group Inc. now owns 7,561,199 shares of the oil and gas company’s stock valued at $320,821,000 after acquiring an additional 60,214 shares in the last quarter. Marshall Wace LLP lifted its position in shares of Delek US by 5.4% in the third quarter. Marshall Wace LLP now owns 101,788 shares of the oil and gas company’s stock valued at $4,319,000 after acquiring an additional 5,230 shares in the last quarter. Finally, Moody National Bank Trust Division purchased a new stake in shares of Delek US in the fourth quarter valued at $3,675,000.
About Delek US
Delek US Holdings, Inc engages in the integrated downstream energy business in the United States. The company's Refining segment processes crude oil and other purchased feedstocks for the manufacture of various grades of gasoline, diesel fuel, aviation fuel, asphalt, and other petroleum-based products that are distributed through owned and third-party product terminals.
Further Reading: How is the Producer Price Index calculated?
To view ValuEngine’s full report, visit ValuEngine’s official website.
Receive News & Ratings for Delek US Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Delek US and related companies with MarketBeat.com's FREE daily email newsletter.